These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20869632)

  • 41. Diagnosis of Lyme disease.
    DePietropaolo DL; Powers JH; Gill JM; Foy AJ
    Del Med J; 2006 Jan; 78(1):11-8. PubMed ID: 16548394
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The use of serologic tests for Lyme disease in a prepaid health plan in California.
    Ley C; Le C; Olshen EM; Reingold AL
    JAMA; 1994 Feb; 271(6):460-3. PubMed ID: 8080498
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of the Modified Two-Tiered Testing Method for Diagnosis of Lyme Disease in Children.
    Lipsett SC; Branda JA; Nigrovic LE
    J Clin Microbiol; 2019 Oct; 57(10):. PubMed ID: 31413078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serologic evidences suggesting the presence of Borrelia burgdorferi infection in Mexico.
    Gordillo G; Torres J; Solorzano F; Cedillo-Rivera R; Tapia-Conyer R; Muñoz O
    Arch Med Res; 1999; 30(1):64-8. PubMed ID: 10071428
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Preparations for serodiagnosis of diseases due to causative agents of ixode tick-borne Borreliosis (Lyme disease). Communication 2. Comparative study of recombinant enzyme immunoassay test-systems (rELISA) for serological diagnosis of ixode tick-borne Borreliosis].
    Manzeniuk IN; Vorob'eva MS; Nikitiuk NM; Arumova EA; Anan'eva LP; Baranova SG; Viatkina TG; Masiago AV; Kozarenko AA; Andreĭchuk IuA
    Antibiot Khimioter; 2004; 49(8-9):25-8. PubMed ID: 15727142
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lyme disease surveillance in the United States, 1983-1986.
    Ciesielski CA; Markowitz LE; Horsley R; Hightower AW; Russell H; Broome CV
    Rev Infect Dis; 1989; 11 Suppl 6():S1435-41. PubMed ID: 2682955
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical evaluation of guidelines and two-test approach for lyme disease.
    Blaauw AA; van Loon AM; Schellekens JF; Bijlsma JW
    Rheumatology (Oxford); 1999 Nov; 38(11):1121-6. PubMed ID: 10556266
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Editorial commentary: laboratory testing for Lyme disease: time for a change?
    Weinstein A
    Clin Infect Dis; 2008 Jul; 47(2):196-7. PubMed ID: 18532894
    [No Abstract]   [Full Text] [Related]  

  • 49. Epidemiology of Lyme disease in Pennsylvania 2006-2014 using electronic health records.
    Moon KA; Pollak J; Hirsch AG; Aucott JN; Nordberg C; Heaney CD; Schwartz BS
    Ticks Tick Borne Dis; 2019 Feb; 10(2):241-250. PubMed ID: 30420251
    [TBL] [Abstract][Full Text] [Related]  

  • 50. No association of seropositivity for anti-Borrelia IgG antibody with mental and physical complaints.
    Grabe HJ; Spitzer C; Lüdemann J; Guertler L; Kramer A; John U; Freyberger HJ; Völzke H
    Nord J Psychiatry; 2008; 62(5):386-91. PubMed ID: 18752103
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Western blotting in evaluating Lyme seropositivity and the utility of a gel densitometric approach.
    Pachner AR; Ricalton NS
    Neurology; 1992 Nov; 42(11):2185-92. PubMed ID: 1436533
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of in vivo expressed Borrelia burgdorferi antigens for improved IgM serodiagnosis of early Lyme disease.
    Brandt KS; Ullmann AJ; Molins CR; Horiuchi K; Biggerstaff BJ; Gilmore RD
    Diagn Microbiol Infect Dis; 2019 Mar; 93(3):196-202. PubMed ID: 30344068
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current Guidelines, Common Clinical Pitfalls, and Future Directions for Laboratory Diagnosis of Lyme Disease, United States.
    Moore A; Nelson C; Molins C; Mead P; Schriefer M
    Emerg Infect Dis; 2016 Jul; 22(7):1169-77. PubMed ID: 27314832
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Updated CDC Recommendation for Serologic Diagnosis of Lyme Disease.
    Mead P; Petersen J; Hinckley A
    MMWR Morb Mortal Wkly Rep; 2019 Aug; 68(32):703. PubMed ID: 31415492
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epidemiology of Lyme disease among US Veterans in Long Island, New York.
    Psevdos G; Khoo T; Chow R; Romano CL; Campbell S
    Ticks Tick Borne Dis; 2019 Feb; 10(2):407-411. PubMed ID: 30573383
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Concordance of four commercial enzyme immunoassay and three immunoblot formats for the detection of Lyme borreliosis antibodies in human serum: the two-tier approach remains.
    Dickeson DJ; Chen SC; Sintchenko VG
    Pathology; 2016 Apr; 48(3):251-6. PubMed ID: 27020501
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intralaboratory reliability of serologic and urine testing for Lyme disease.
    Klempner MS; Schmid CH; Hu L; Steere AC; Johnson G; McCloud B; Noring R; Weinstein A
    Am J Med; 2001 Feb; 110(3):217-9. PubMed ID: 11182109
    [No Abstract]   [Full Text] [Related]  

  • 58. Searching for Lyme borreliosis in Australia: results of a canine sentinel study.
    Irwin PJ; Robertson ID; Westman ME; Perkins M; Straubinger RK
    Parasit Vectors; 2017 Mar; 10(1):114. PubMed ID: 28285585
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Feedback on difficulties raised by the interpretation of serological tests for the diagnosis of Lyme disease.
    Hansmann Y; Leyer C; Lefebvre N; Revest M; Rabaud C; Alfandari S; Christmann D; Tattevin P
    Med Mal Infect; 2014 May; 44(5):199-205. PubMed ID: 24794819
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Laboratory diagnosis of infection caused by Borrelia burgdorferi].
    Dessau RB; Bangsborg JM; Jensen TP; Hansen K; Lebech AM; Andersen CØ
    Ugeskr Laeger; 2006 Aug; 168(34):2805-7. PubMed ID: 16942701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.